Literature DB >> 33910371

Soluble CD14 Levels in the Jackson Heart Study: Associations With Cardiovascular Disease Risk and Genetic Variants.

Maggie A Stanislawski1, Leslie A Lange1,2, Laura M Raffield3, Neil A Zakai4,5, Mariah Meyer1, Kendra Ferrier1, Mindy D Szeto1, Colton Leavitt1, Jonathan A Shortt1, Timothy A Thornton6, Russell P Tracy4,7, Paul L Auer8, Alex P Reiner9, Ethan M Lange1,10, Nels C Olson4.   

Abstract

[Figure: see text].

Entities:  

Keywords:  cardiovascular disease; genetics; heart failure; inflammation; risk

Mesh：

Substances：

Year:  2021        PMID： 33910371      PMCID： PMC8159903          DOI： 10.1161/ATVBAHA.121.316035

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   10.514


  40 in total

1.  Study design for genetic analysis in the Jackson Heart Study.

Authors:  James G Wilson; Charles N Rotimi; Lynette Ekunwe; Charmaine D M Royal; Mary E Crump; Sharon B Wyatt; Michael W Steffes; Adebowale Adeyemo; Jie Zhou; Herman A Taylor; Cashell Jaquish
Journal:  Ethn Dis       Date:  2005       Impact factor: 1.847

2.  RFMix: a discriminative modeling approach for rapid and robust local-ancestry inference.

Authors:  Brian K Maples; Simon Gravel; Eimear E Kenny; Carlos D Bustamante
Journal:  Am J Hum Genet       Date:  2013-08-01       Impact factor: 11.025

3.  Quantification of coronary artery calcium using ultrafast computed tomography.

Authors:  A S Agatston; W R Janowitz; F J Hildner; N R Zusmer; M Viamonte; R Detrano
Journal:  J Am Coll Cardiol       Date:  1990-03-15       Impact factor: 24.094

4.  Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.

Authors:  Ruben Poesen; Ali Ramezani; Kathleen Claes; Patrick Augustijns; Dirk Kuypers; Ian R Barrows; Jagadeesan Muralidharan; Pieter Evenepoel; Björn Meijers; Dominic S Raj
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-07       Impact factor: 8.237

Review 5.  Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association.

Authors:  Victor Aboyans; Michael H Criqui; Pierre Abraham; Matthew A Allison; Mark A Creager; Curt Diehm; F Gerry R Fowkes; William R Hiatt; Björn Jönsson; Philippe Lacroix; Benôit Marin; Mary M McDermott; Lars Norgren; Reena L Pande; Pierre-Marie Preux; H E Jelle Stoffers; Diane Treat-Jacobson
Journal:  Circulation       Date:  2012-11-16       Impact factor: 29.690

6.  Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients.

Authors:  Dominic S C Raj; Juan J Carrero; Vallabh O Shah; Abdul R Qureshi; Peter Bárány; Olof Heimbürger; Bengt Lindholm; Jennet Ferguson; Pope L Moseley; Peter Stenvinkel
Journal:  Am J Kidney Dis       Date:  2009-09-06       Impact factor: 8.860

7.  TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study.

Authors:  P E Morange; L Tiret; N Saut; G Luc; D Arveiler; J Ferrieres; P Amouyel; A Evans; P Ducimetiere; F Cambien; I Juhan-Vague
Journal:  Eur J Hum Genet       Date:  2004-12       Impact factor: 4.246

8.  A global reference for human genetic variation.

Authors:  Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis
Journal:  Nature       Date:  2015-10-01       Impact factor: 49.962

9.  Interaction of CD14 haplotypes and soluble CD14 on pulmonary function in agricultural workers.

Authors:  Tricia D LeVan; Lynette M Smith; Art J Heires; Ted R Mikuls; Jane L Meza; Lisa A Weissenburger-Moser; Debra J Romberger
Journal:  Respir Res       Date:  2017-03-16

10.  Genome-wide study of immune biomarkers in cerebrospinal fluid and serum from patients with bipolar disorder and controls.

Authors:  Sarah E Bergen; Mikael Landén; Ruyue Zhang; Jie Song; Anniella Isgren; Joel Jakobsson; Kaj Blennow; Carl M Sellgren; Henrik Zetterberg
Journal:  Transl Psychiatry       Date:  2020-02-05       Impact factor: 6.222
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.